Guiding researchers with cutting edge dPCR technology | Digital PCR

Clinical researchers are on a quest for breakthroughs in treatment and care. But the pressure is immense. They have to race against the clock to reach milestones to ensure continued funding, and rarely have time to keep track of which technologies are constantly being developed. Not only that, but faster and more reliable data means new treatments makes it to the patient bedside sooner. And this is exactly what inspired Mogens Kruhøffer to build a company to support clinical research groups.

🔥 Subscribe to our channel now

“Our mission is to support clinical research groups in hospitals and in universities, biotech companies, and pharma in their research,” explains Mogens Kruhøffer, founder and CEO of BioXpedia. They are currently working with the British company PreSymptom Health that is developing a gene expression signature to tell if patients are going to develop sepsis, for example. “We are always listening to what they need for their research and implementing the applications and workflows in our laboratories.” Their most recent addition to the lab, the QIAcuity, will allow them to provide better results and even faster. Ultimately, “I'm interested in accelerating the research from idea to bedside for the benefit of patients,” explains Kruhøffer.

Find out more now 👉

..............................................................
Follow us now
..............................................................

#QIAGEN #SampletoInsight #dPCR #DigitalPCR